Zobrazeno 1 - 7
of 7
pro vyhledávání: '"von Arnstedt, Eva"'
Autor:
Schuster, Reinhard, Heidbreder, Marc, Schuster, Fabian, von Arnstedt, Eva, Ostermann, Thomas, Schuster, Martin, Emcke, Timo
Publikováno v:
24. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie; 20171130-20171201; Erfurt; DOC17gaa90 /20171205/
Background: Drug prescription data structure in outpatient treatment (described by § 300 SGB V (Volume V of the Social Insurance Code in German Law)), diagnostic data in outpatient treatment (using ICD-10), remedy prescription data (§ 302 SGB V) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c034c471d8e77f410564726c547ab41
http://www.egms.de/en/meetings/gaa2017/17gaa90.shtml
http://www.egms.de/en/meetings/gaa2017/17gaa90.shtml
Publikováno v:
24. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie; 20171130-20171201; Erfurt; DOC17gaa107 /20171205/
Background: Since the launch of the direct oral anticoagulants (DOAC) rivaroxaban, dabigatran, apixaban and edoxaban in Germany there is an ongoing debate about the cost effectiveness of anticoagulant treatment. Looking at the GAMSI data (prescriptio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30a2fff509ab4204d881b628eccf3151
Publikováno v:
24. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie; 20171130-20171201; Erfurt; DOC17gaa106 /20171205/
Background: In 2011, the Act on the Reform of the Market for Medical Products (AMNOG) came into effect. From that point, pharmaceutical companies are legally obligated to submit a dossier to the Federal Joint Committee (G-BA) in order to prove a pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbff37a3262a4139f6ee7c7cd2f9f2c8
http://nbn-resolving.de/urn:nbn:de:0183-17gaa1064
http://nbn-resolving.de/urn:nbn:de:0183-17gaa1064
Publikováno v:
23. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie; 20161124-20161125; Bochum; DOC16gaa08 /20161123/
Background: A recent analysis of prescriptions of benzodiazepines and Z-drugs revealed that the first month of each quarter showed a maximum number of prescriptions and in the following month a minimal number of prescriptions (cf. Figure 1 [img:Bild
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2d43daf07ce8fe07d463036cd5be9eb
Publikováno v:
20. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie; 20131205-20131206; Düsseldorf; DOC13gaa32 /20131125/
Background: Benzodiazepines (BZD) are extensively applied for treatment of a multitude of psychic aberrations including conditions of agitation or a variety of sleep disorders. Regarding latter indication, BZD are more and more replaced by Z-hypnotic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e14ee6d46dbfb0f1934166ce857239d2
http://nbn-resolving.de/urn:nbn:de:0183-13gaa329
http://nbn-resolving.de/urn:nbn:de:0183-13gaa329
Autor:
Schuster, Reinhard, Von Arnstedt, Eva
Publikováno v:
19. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie; 20121122-20121123; Jena; DOC12gaa04 /20121114/
Background: Multimedication in connection with multimorbidity is focused on older patients and offers many challenges in medical care. We will consider empirical results of the 5 year survival rate of patients with multimedication compared with other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ec57a85d72a5356f1bfedc129f68002
Publikováno v:
Studies in Health Technology & Informatics; 2016, Vol. 228, p783-787, 5p, 6 Charts
